1Xu M, Aita M, Chavkin C. Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: behavioral, neural, and glial reactions [ J ]. Pain, 2008, 9 : 1036 - 1048.
2Moalem G, Traeey DJ. Immune and inflammatory mechanisms in neuropathic pain[J]. Brain Res Rev, 2006, 51:240-264.
3Sung B, Lira G, Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathie pain in rats [J]. J Neurosci, 2003, 23:2899 -2910.
4Wang S, Lira G, Yang L,et al. Downregulation of spinal glutamate transporter EAAC1 following nerve injury is regulated by central glucocorticoid receptors in rats[ J]. Pain, 2006, 120:78 - 85.
5Tsakiri N, Kimber I, Ptothwell N J, et al. Differential effects of interleukin-1 alpha and beta on interleukin45 and chemokine synthesis in neurons[ J]. Mol Cell Neurosci, 2008, 38:259 - 265.
6Gustafson-Vickers SL, Lu VB, Lai AY, et al. Long-term actions of interleukin-1 on delay and tonic firing neurons in rat superficial dorsal horn and their relevance to central sensitization[ J ]. Mol Pain, 2008, 4:63.
7Woff G, Gabay E, Tal M, et al. Genetic impairment of interleukin- 1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury, in mice[ J]. Pain, 2006, 120:315-324.
8Arruda JL, Colbum RW, Rickman A J, et al. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathie pain[J].Mol Brain Res, 1998, 62:228 - 235.
9Ledeboer A, Jekich BM, Sloane EM, et al. lntrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats[J]. Brain Behav hnmun, 2007, 21:686 -698.
10Hensellek S, Brell P, Schaible HG,et al. The cytokine TNF-α increases the proportion of DRG neurons expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation[J].Mol Cell Neurosci, 2007, 36:381 - 391.
3Ji RR, Wooff CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001; 8 (1): 1-10.
5Borsook D, Ploghaus A, Becerra L. Utilizing brain imaging for analgesic drug development. Curr Opin Investig Drugs 2002; 3 (9): 1342-1347.
6Casey KL, Lorenz J, Minoshima S. Insights into the patho-physiology of neuropathic pain through functional brain imaging. Exp Neurol 2003; 184 (Suppl 1):S80-88.
7Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol 2004; 58: 253-271.
8Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther 2001; 8 (7): 551-556.
9Hao S, Mata M, Goins W, Glorioso JC, Fink DJ. Transgene- mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect. Pain 2003; 102: 135-142.
5Inoue S, Kawakami T, Seo N. A comparison of morphine con- centrations for patients-controlled epidural analgesia following gynecological surgery [J]. Minerva Anestesiol, 2009,75(9): 498-503.
6Chen L M, Weinberg V K, Chert C, et al. Perioperative out- comes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery [J]. Gynecol Oncol, 2009,115(3) :357-361.
7Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin- 1alpha, and interleukin-lbeta [J]. J Neurosci, 2002,22(8): 3052-3060.
8Sweitzer S, Martin D, Deleo J A. Intrathecal interleukin-1 re- ceptor antagonist in combination with soluble tumor necrosis fac- tor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain [J]. Neuroscience, 2001,103(2) :529-539.
